IDEX Corporation (IEX)

NYSE: IEX · USD

$239

+5.69 (+2.4%)· Recorded snapshot

영어 원본으로 대체KO

번역하는 동안 영어 원본을 표시 중

이 리포트는 아직 번역되지 않았습니다. 번역 대기열이 따라잡으면 몇 분 후에 새로고침하세요.

StockMarketAgent Research · Analyzed 2026-10-11

Our latest published analysis: IEX rated Sell

IDEX Corporation's published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.

Fair value

$168 / share

Potential value

$185 / share

Upside to FV

-28.1%

from $239

Moat

7.5/10

Narrow

Read full analysis →View archive · 24mo

9-phase methodology · same model in each published edition

Market cap	$17.3B
Revenue (ttm)	3.7B
Net income (ttm)	535.8M
EPS (ttm)	$7.20
Shares out	73.7M
P/E (trailing)	33.2x
P/E (forward)	24.0x
Dividend	$2.92 (1.23%)
Volume	1,410,847
Beta	0.96

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 3.7B
Net income (ttm): 535.8M
EPS (ttm): $7.20
P/E (trailing): 33.2x
P/E (forward): 24.0x
Market cap: $17.3B

Item	P1	P2	P3	P4	P5	Trend
Period	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31	Trend
Revenue	$2.76B	$3.18B	$3.27B	$3.27B	$3.46B	+5.7%
Gross profit	$1.22B	$1.43B	$1.45B	$1.45B	$1.54B	+5.9%
Operating income	$637.0M	$751.4M	$732.5M	$677.2M	$699.3M	+2.4%
Net income	$449.4M	$586.9M	$596.1M	$505.0M	$483.2M	+1.8%
EPS (diluted)	$5.88	$7.71	$7.85	$6.64	$6.41	+2.2%
EBITDA	$720.5M	$909.8M	$732.5M	$859.4M	$903.5M	+5.8%
R&D	$50.1M	$61.4M	$68.4M	$67.4M	$70.0M	+8.7%
SG&A	$578.2M	$652.7M	$703.5M	$758.7M	$818.8M	+9.1%

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ABBV	AbbVie Inc.	505.6B	80.8x	7.9x	17.7%	+3.7%	+29.1%	매도
ABT	Abbott Laboratories	177.6B	38.2x	3.7x	7.2%	+2.7%	-17.2%	비중 축소
ACN	Accenture plc	144.3B	18.0x	2.0x	27.9%	+8.0%	+0.4%	보유
AAL	American Airlines Group Inc.	8.3B	—	0.1x	3.0%	+20.0%	-6.9%	보유
ADP	Automatic Data Processing, Inc.	113B	25.3x	5.1x	62.8%	+7.7%	+4.5%	보유
ALLE	Allegion plc	15.2B	22.5x	3.5x	19.4%	+8.8%	+7.2%	보유

Base and Bull scenarios

Base55%

Price target

$168.38

-28.1% from spot

Under the base case, IDEX achieves organic revenue growth accelerating into 5%-6% in FY2026, consistent with raised management guidance, followed by 5.99% in FY2027. Operating margin expands from 20.23% in FY2025 toward 23.2% by FY2030 through disciplined 80/20 operational execution. Diluted EPS increases from $6.41 in FY2025 to $8.83 in FY2026 and $9.63 in FY2027. At an exit P/E of 21.0x, in line with mature peer ITW (21.40x), intrinsic value aligns with the house Fair value midpoint of $168.38.

Consolidated revenue growth of 6.74% in FY2026 and 5.99% in FY2027 fading to 4.5% by FY2030.
Operating margin expands from 20.23% in FY2025 to 21.5% in FY2026 and reaches 23.2% by FY2030.
Share repurchases retire ~0.7% to 1.0% of diluted shares annually, funded by steady operating cash flows.
Terminal exit P/E multiple of 21.0x, aligning with mature high-grade peer ITW (21.40x).

Bull20%

Price target

$185.31

-20.9% from spot

Under the bull case, rapid commercial adoption of liquid cooling manifolds in hyperscale AI data centers and surging semiconductor fab tool installations accelerate organic revenue growth above 8% annually. Operating margins expand toward 25.0%, approaching specialized peers Nordson (27.40%) and ITW (26.90%), lifting potential intrinsic value toward $185.31.

HST segment revenue grows at low double digits through 2028 on sustained data center liquid cooling adoption.
Consolidated operating margin expands to 25.0%, closing the gap toward specialized peer Nordson (27.40%).
Terminal exit P/E multiple expands reflecting market recognition of higher secular growth mix.

Sensitivity: Ke × terminal growth

The highlighted cell is Fair value when every assumption sits at its base level ($168.38). Each row and column shows what Fair value becomes when one assumption moves.

Ke ↓ / g →	1.5%	2.0%	2.5%	3.0%	3.5%
8.2%	$175	$184	$196	$209	$225
8.7%	$164	$172	$181	$192	$205
9.2%	$154	$161	$168	$177	$188
9.7%	$145	$151	$158	$165	$174
10.2%	$137	$142	$148	$155	$162

Scorecard

Published factor rows and weighted composite

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E24

P25 n/aP50 n/aP75 n/a

Trailing P/E33.7

P25 n/aP50 n/aP75 n/a

ROE13.3

P25 n/aP50 n/aP75 n/a

ROIC11.5

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All IEX indicators

Market & fundamental data

Available fields

290

Groups with data

Currency

USD

Showing 290 of 290 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0000832101
Company name	IDEX Corporation
Country	United States
Country code	US
CUSIP number	45167R104
Earnings date	2026-10-28
Earnings time	bmo
Employees	8,700
Employees change	-300
Employees growth	-3.33%
Enterprise value	$18.8B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-05-09
Fiscal year end	December
Founded	1987
In index	SP500
Industry	Specialty Industrial Machinery
IPO date	1991-06-21
Is primary listing	Yes
Is SPAC	No
ISIN number	US45167R1041
Last 10-K release date	2026-02-19
Last earnings date	2026-10-28
Last refreshed	2026-10-28
Last stock split date	2007-05-22
Last stock split type	Forward
Market cap	$17.6B
Market cap category	Large-Cap
Next earnings date	2027-02-03
Options	Yes
Price	$238.90
Price currency	USD
Sector	Industrials
SIC code	3561
Stock price date	2026-10-28
Symbol	IEX
U.S. state	Illinois
Website	https://www.idexcorp.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	27.3x
Average P/E ratio (10Y)	30.19x
Average P/E ratio (3Y)	29.3x
Average P/E ratio (5Y)	29.38x
Earnings yield	3.01%
EV/Earnings	34.84x
EV/EBIT	23.79x
EV/EBITDA	18.69x
EV/FCF	27.98x
EV/Sales	5.1x
FCF / EV yield	3.57%
FCF yield	3.81%
Forward EV/Sales	4.83x
Forward P/E	25.03x
Forward P/S	4.53x
Graham number	93.9646
Graham upside	-60.46%
Industry forward P/E	24.96x
Industry P/E	31.67x
Lynch fair value	$36.00
Lynch upside	-84.85%
P/(FCF - SBC) ratio	27.55x
P/(OCF - SBC) ratio	24.28x
P/B ratio	4.28x
P/E ratio	33.18x
P/FCF ratio	26.26x
P/OCF ratio	23.27x
P/S ratio	4.79x
PEG ratio	2.05x
Price/EBITDA ratio	17.54x
Sector forward P/E	26.24x
Sector P/E	40.28x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	21.45%
EBITDA margin	27.3%
Effective tax rate	23.87%
FCF margin	18.24%
Gross margin	44.89%
Operating margin	21.45%
Pretax margin	19.23%
Profit margin	14.65%
Profit per employee	$61,586
Profitable quarters	54
Profitable years	34
Revenue per employee	$420,494
ROA	7.08%
ROA (5Y)	8.02%
ROCE	12.57%
ROE	13.35%
ROE (5Y)	16.22%
ROIC	11.45%
ROIC (5Y)	13.89%
SBC / revenue	0.85%
Tax / revenue	4.59%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	13.93%
EPS growth (Q)	14.71%
EPS growth (QoQ)	1.04%
EPS growth 10Y	7.03%
EPS growth 3Y	-3.96%
EPS growth 5Y	5.05%
EPS growth quarters	4
EPS growth years	0
FCF growth	14.21%
FCF growth (Q)	13.57%
FCF growth (QoQ)	21.07%
FCF growth 3Y	3.9%
FCF growth 5Y	5.69%
Gross profit growth	7.72%
Gross profit growth (Q)	9.79%
Gross profit growth 3Y	3.87%
Gross profit growth 5Y	6.63%
Net income growth	12.07%
Net income growth (Q)	12.75%
Net income growth (QoQ)	0.49%
Net income growth 3Y	-4.62%
Net income growth 5Y	4.42%
Net income growth quarters	4
Net income growth years	0
OCF growth	16.97%
OCF growth (Q)	17.69%
OCF growth (QoQ)	19.75%
OCF growth 10Y	6.99%
OCF growth 3Y	3.29%
OCF growth 5Y	5.96%
Operating income growth	10.02%
Operating income growth (Q)	12.21%
Operating income growth 3Y	0.41%
Operating income growth 5Y	4.49%
Revenue growth	6.93%
Revenue growth (Q)	8.31%
Revenue growth (QoQ)	3.38%
Revenue growth 10Y	5.8%
Revenue growth 3Y	3.54%
Revenue growth 5Y	6.54%
Revenue growth quarters	8
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-85.6M
Depreciation and amortization	$214M
EBIT	$784.8M
EBITDA	$998.8M
EPS	$7.20
FCF per share	$9.05
Financing cash flow	$-649.1M
Free cash flow	$667.1M
Free cash flow minus SBC	$635.9M
Gross profit	$1.6B
Income taxes	$167.9M
Investing cash flow	$-85.3M
Net borrowing	$-148M
Net cash flow	$7.4M
Net income	$535.8M
Operating cash flow minus SBC	$721.5M
Operating income	$784.8M
Revenue	$3.7B
Stock-based compensation	$31.2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	$54.50
Debt / EBITDA	1.73
Debt / equity	0.44
Debt / FCF	2.63
Goodwill	$3.4B
Interest coverage	12.52
Long-term assets	$5.1B
Long-term liabilities	$2.2B
Net cash (debt)	$-1.1B
Net cash / market cap	-6.56%
Net debt / EBITDA	1.15
Net debt / equity	0.29
Net debt / FCF	1.72
Piotroski F-Score	7
Property, plant and equipment	$466.9M
Shareholders' equity	$4B
Tangible book value	$-484.4M
Tangible book value per share	$-6.57
Total assets	$6.9B
Total cash	$602.1M
Total debt	$1.8B
Total liabilities	$2.9B
WACC	8.91%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.53
Current assets	$1.8B
Current liabilities	$635.9M
Current ratio	2.78
Inventory turnover	3.94
Net working capital	$528.9M
Quick ratio	1.81
Working capital	$1.1B
Working capital turnover	3.29

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.69%
Dividend growth	2.84%
Dividend growth (10Y)	8.03%
Dividend growth (3Y)	4.79%
Dividend growth (5Y)	6.47%
Dividend growth years	16
Dividend payment date	2026-10-16
Dividend payment years	32
Dividend payout frequency	Quarterly
Dividend per share	$2.92
Dividend yield	1.23%
Ex-dividend date	2026-10-02
FCF payout ratio	33.56%
Last dividend	$0.73
Payout ratio	42%
Shareholder yield	2.92%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	176.58%
10Y return CAGR	12.11%
10Y total return	213.5%
150-day SMA	$220.91
15Y price change	551.58%
15Y return CAGR	14.9%
15Y total return	702.79%
1D price change	2.44%
1M price change	3.39%
1M total return	3.72%
1W price change	2.03%
1W total return	2.03%
1Y price change	41.94%
1Y return CAGR	43.93%
1Y total return	43.89%
20-day SMA	$233.87
200-day SMA	$215.74
20Y price change	662.3%
20Y return CAGR	12.32%
20Y total return	920.34%
3M price change	6.28%
3M total return	6.62%
3Y price change	24.6%
3Y return CAGR	9.11%
3Y total return	29.89%
50-day SMA	$230.01
50-day SMA vs 200-day SMA	50over200
52-week high	$243.80
52-week high date	2026-07-29
52-week low	$160.60
52-week low date	2025-11-19
5Y price change	7.05%
5Y return CAGR	2.7%
5Y total return	14.26%
6M price change	14.71%
6M total return	15.86%
All-time high	$246.36
All-time high date	2024-03-22
All-time low	$2.94
All-time low date	1991-11-22
Average true range (ATR)	$5.49
Average volume	722.8K
Beta (1Y)	0.52
Beta (2Y)	0.92
Beta (5Y)	0.96
Change from 52-week high	-2.01%
Change from 52-week low	48.76%
Change from all-time high	-3.44%
Change from all-time low	7,997%
Change from open	0.38%
Day's gap	2.05%
Dollar volume	$337.1M
High price	$239.44
Low price	$230.89
Monthly RSI	61.99
Open price	$237.99
Position in 52-week range	93.68%
Premarket change	-0.3%
Premarket close	$233.21
Premarket price	$232.50
Previous close	$233.21
Price vs 150-day SMA	7.69%
Price vs 20-day SMA	1.72%
Price vs 200-day SMA	10.27%
Price vs 50-day SMA	3.42%
Relative volume	1.95
RSI	58.92
Sharpe ratio	1.57
Sharpe ratio (3Y)	0.3
Sharpe ratio (5Y)	0.08
Sortino ratio	2.87
Sortino ratio (3Y)	0.66
Sortino ratio (5Y)	0.35
Volume	1.4M
Weekly RSI	63.31
YTD price change	33.69%
YTD total return	35.53%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	73.5M
Float percentage	99.71%
Shares change (QoQ)	-0.27%
Shares change (YoY)	-1.69%
Shares held by insiders	0.2%
Shares held by institutions	104.35%
Shares outstanding	73.7M
Short % of float	3.43%
Short % of shares	3.42%
Short ratio	4.3 days

Deeper analysis on IEX

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Quote this valuation with its source: Fair value, Potential value and the price at analysis.

Frequently asked questions

About this IEX report

What is the latest published IEX stock rating?

IDEX Corporation is shown with Sell in the latest published report, analyzed 2026-10-11. The hub links directly to the full analysis surface where the dated rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full IEX analysis?

The full latest published report, analyzed 2026-10-11, lives at /stocks/IEX/analysis. The bare ticker page summarizes that read and links to each analysis tab; earlier editions remain under /analysis/archive.

What fair value is used for IEX?

The latest published report analyzed 2026-10-11 gives IEX a fair value of USD 168 and a potential value of USD 185. These are dated research outputs, not live market prices; review the valuation assumptions, sensitivity analysis, and material risks before making a decision.

How often is the IEX page updated?

The hub selects the latest published stock report regardless of age and displays its analysis date (2026-10-11). Separately sourced market data is labeled with its own recorded timestamp and is never inferred from the report.

SellIEX · Fair value $168-28.1%

Read full analysis →

IDEX Corporation (IEX)

Our latest published analysis: IEX rated Sell

Price

Financial snapshot

Fair-value bridge

Latest news · IEX

Valuation

Profitability

Balance sheet

Trading

Base and Bull scenarios

Sensitivity: Ke × terminal growth

Scorecard

Next earnings

Sector percentile context

All IEX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on IEX

Frequently asked questions

등급 이력

Category	Score	Reading
Valuation	1.5
Management	8.5
Balance Sheet	7.5
Profitability	5.5
Revenue Growth	6.0
Risk Assessment	7.0
Competitive Moat	7.5
Earnings Quality	8.0
Capital Efficiency	5.5